Outcome of the 246th Board Meeting of the Board of Directors of Novartis India Limited held today i.e, Wednesday, July 29, 2026.

Novartis India Limited July 29, 2026 The Secretary, BSE Limited, Phiroze Jejeebhoy Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 500672. Dear Sir / Ma’am, Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the “Listing Regulations”) Ref: Outcome of 246th meeting of the Board of Directors held on July 29, 2026, and other disclosures. We hereby inform that the board of directors of the Company (“Board”), at its 246th meeting held today, i.e., July 29, 2026, has inter-alia, noted/ approved the following matters: A. Reconstitution of Committees The Audit Committee, Nomination Remuneration Committee, Corporate Social Responsibility Committee of the board of the Company have been re-constituted due to appointment and resignation of directors, in compliance with the requirements of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The details of the re-constituted committees are set forth in Annexure I. The meeting of the Board commenced at 05.50 P.M. and concluded at 06.10 P.M. The above is for your information and the same is also available on the website of the Company i.e. www.nilpharma.co.in Yours faithfully, For Novartis India Limited Chandni Maru Company Secretary and Compliance Officer Encl.: as above Registered Office: Inspire BKC, 7th Floor, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra, India. CIN: L24200MH1947PLC006104 | Tel: +91 22 50243000 Email: investor.relations@nilpharma.co.in | Website: www.nilpharma.co.in Novartis India Limited Annexure I 1. Reconstitution of the Audit Committee: Sr. No Name of the Committee Designation of the Position of the Member Director Director in the Committee 1. Ms. Suchita Sharma Additional Director Chairperson (under the independent director category) 2. Mr. Shashank Sinha Additional Director Member (under the independent director category) 3. Mr. Ramesh Ramadurai Additional Director Member (under the independent director category) 4. Ms. Jagriti Gupta Additional Director Member (under the non- executive, non- independent director category) 2. Reconstitution of the Nomination and Remuneration Committee: Sr. No Name of the Committee Member Designation of the Position of the Director Director in the Committee 1. Mr. Shashank Sinha Additional Director Chairperson (under the independent director category) 2. Mr. Ramesh Ramadurai Additional Director Member (under the independent director category) 3. Mr. Kshitij Sheth Additional Director Member (under the non- executive, non- independent director category) Registered Office: Inspire BKC, 7th Floor, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra, India. CIN: L24200MH1947PLC006104 | Tel: +91 22 50243000 Email: investor.relations@nilpharma.co.in | Website: www.nilpharma.co.in Novartis India Limited 3. Reconstitution of the Corporate Social Responsibility Committee: Sr. No. Name of the Committee Member Designation of the Position of the Director Director 1. Mr. Ashok Bhatia Additional Director Chairperson (under the non- executive, non- independent director category) 2. Mr. Ramesh Ramadurai Additional Director Member (under the independent director category) 3. Ms. Suchita Sharma Additional Director Member (under the independent director category) Registered Office: Inspire BKC, 7th Floor, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra, India. CIN: L24200MH1947PLC006104 | Tel: +91 22 50243000 Email: investor.relations@nilpharma.co.in | Website: www.nilpharma.co.in